RALEIGH, N.C. & OKLAHOMA CITY & CHICAGO–(BUSINESS WIRE)–Lumata Health announces its partnership with Prevent Blindness to collaborate on various initiatives to address barriers to care for patients.
Author: Business Wire
Horizon Therapeutics plc Announces Positive Topline Data from TEPEZZA® (teprotumumab-trbw) Phase 4 Clinical Trial in Patients with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED)
DUBLIN–(BUSINESS WIRE)–Horizon announces positive topline data from TEPEZZA® Phase 4 clinical trial in chronic/low clinical activity score (CAS) Thyroid Eye Disease (TED).
Ora, Inc. Appoints Paul Colvin as Chief Operating Officer
BOSTON–(BUSINESS WIRE)–Ora, Inc., world’s leading CRO for ophthalmology pharmaceutical and device development, announces Paul Colvin appointment as Chief Operating Officer.
HORUS PHARMA GROUP LANSERAR ETT NORDISKT DOTTERBOLAG
STOCKHOLM–(BUSINESS WIRE)–Horus Pharma, ett oberoende franskt laboratorium specialiserat på oftalmologi, har tagit ett stort steg i sin europeiska expansionsstrategi genom att starta ett nytt dotterbolag. Från sin bas i Stockholm kommer Horus Pharma …
HORUS PHARMA GROUP LANSERER ET NORDISK DATTERSELSKAP
STOCKHOLM–(BUSINESS WIRE)–Horus Pharma, et uavhengig fransk laboratorium som har spesialisert seg på oftalmologi, har tatt et viktig steg i sin europeiske ekspansjonsstrategi med åpningen av et nytt datterselskap. Fra sin base i Stockholm vil Horus P…
HORUS PHARMA GROUP KÄYNNISTÄÄ TOIMINTANSA POHJOISMAISSA
TUKHOLMA–(BUSINESS WIRE)–Ranskalainen oftalmologian alaan erikoistunut riippumaton laboratorio Horus Pharma on nyt ottanut merkittävän askeleen Euroopan laajentumisstrategiassaan avaamalla uuden tytäryhtiönsä. Uuden Horus Pharma Nordic -yhtiön sijain…
HORUS PHARMA GROUP LANCERER ET NORDISK DATTERSELSKAB
STOCKHOLM–(BUSINESS WIRE)–Horus Pharma, et uafhængigt fransk laboratorium med speciale i oftalmologi, har taget et stort skridt i sin europæiske ekspansionsstrategi med åbningen af sit nye datterselskab. Fra sin base i Stockholm vil Horus Pharma Nord…
Horus Pharma Group Launches a Nordic Subsidiary
STOCKHOLM–(BUSINESS WIRE)–Horus Pharma, an independent French laboratory specialised in ophthalmology, has taken a major step in its European expansion strategy with the opening of its new subsidiary. From its base in Stockholm, Sweden, Horus Pharma …
Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment
DALLAS–(BUSINESS WIRE)–Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment
Mojo Vision Raises $22.4M in First Close of New Series A Round for Development of High Performance Micro-LED Technology
SARATOGA, Calif.–(BUSINESS WIRE)–Mojo Vision, the high-performance micro-LED company, today announced a $22.4 million new Series A investment round to propel the development and commercialization of its micro-LED display technology for consumer, ente…
Exegenesis Bio To Present Five Posters at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, Los Angeles, CA, May 16-20, 2023
PHILADELPHIA–(BUSINESS WIRE)– #biotechnology–Exegenesis Bio, a rapidly growing global gene therapy company is pleased to announce the presentation of five posters at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in Los Angeles…
Blue Point Announces Investment in Europa Eyewear to Support Growth and Development of New Platform
CLEVELAND–(BUSINESS WIRE)–Blue Point Capital Partners is pleased to announce, in partnership with management, the recapitalization of Europa Eyewear, a family-owned designer and manufacturer of proprietary eyewear frames primarily serving the indepen…
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PARSIPPANY, N.J.–(BUSINESS WIRE)–Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to nine newly-hired, non-executive employees.
Radius Delivers Immersive Perimetry at the Speed of Business
PLEASANTON, Calif.–(BUSINESS WIRE)– #Ophthalmology–Radius XR®, the wearable digital healthcare technology brand, has launched its Radius 1.0 software release, challenging the gold standard in perimetric examinations. Its fast and reliable interface …
TearRestore Announces First of Its Kind Dry Eye Solutions; Now Available at Target Nationwide
ST. PAUL, Minn.–(BUSINESS WIRE)–TearRestore, who offers a suite of FDA cleared products that support dry eye relief, today announced its Thermal Mask and Eyelid Wipes will now be available at Target stores nationwide and at Target.com. Both products …
Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent’s Ongoing Orion Clinical Study
EMERYVILLE, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an emerging biopharmaceutical company which develops miniaturized, subdermal implants today announced that the Company received notice from the Nation…
Aviceda Announces 3 Presentations about AVD-104, its Lead Glyco-mimetic Nanoparticle, As a Novel Treatment for Geographic Atrophy from Macular Degeneration, at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, April 2023
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aviceda Therapeutics, a private biotech company focused on developing the next generation immuno-modulators by harnessing the power of glycobiology to modulate the innate immune system and alleviate chronic, non-resol…
ABIONYX Pharma Announces Its Strategy in Ophthalmology and New Positive Preclinical Results for the Deployment of Two Innovative Technology Platforms: Apotherapy and Biovectorization
TOULOUSE, France & LAKELAND, Mich.–(BUSINESS WIRE)–ABIONYX Pharma, (FR0012616852 – ABNX – PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today announced today annou…
NovaBay Pharmaceuticals Reports 2022 Fourth Quarter and Full Year Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2022 and provides a business update. Financial results for 2022 include DERMAdoctor®, whic…
WaveFront Dynamics Inc. Launches WaveDȳn® Vision Analyzer
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. announces the commercial launch of new dynamic aberrometer, the WaveDȳn®️ Vision Analyzer